Key terms
About ENFN
Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. It is a software-as-a-service firm that develops a platform to eliminate technology and information barriers, and simplify investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset. The company was founded by Tarek Hammoud, Stephen M. Malherbe, Oleg Movchan, and Scott Werner in 2006 and is headquartered in Chicago, IL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ENFN news
Mar 21
3:45pm ET
Enfusion’s Growth Strategy Met with Sell Rating Amid Market and Strategic Challenges
Mar 21
8:00am ET
Analysts’ Opinions Are Mixed on These Technology Stocks: GoDaddy (GDDY) and Enfusion (ENFN)
Mar 20
7:16am ET
Enfusion (ENFN) Gets a Hold from Piper Sandler
Mar 20
7:16am ET
Stifel Nicolaus Keeps Their Buy Rating on Enfusion (ENFN)
Mar 20
5:10am ET
Analysts Have Conflicting Sentiments on These Technology Companies: Marvell (MRVL) and Enfusion (ENFN)
Mar 19
5:35pm ET
Enfusion (ENFN) Gets a Buy from William Blair
Mar 19
8:25am ET
Enfusion to hold an analyst and investor day
Mar 19
6:42am ET
Enfusion’s Upcoming Investor Day and Information Disclosure
Mar 17
2:49pm ET
Enfusion to hold an analyst and investor day
Mar 13
7:21am ET
Enfusion price target raised to $9 from $8 at BofA
Mar 13
7:01am ET
Analysts Offer Insights on Technology Companies: Repay Holdings (RPAY), Instructure Holdings (INST) and Enfusion (ENFN)
Mar 13
6:41am ET
Analysts Offer Insights on Technology Companies: Copperleaf Tech (OtherCPLFF), Rackspace Technology (RXT) and Enfusion (ENFN)
Mar 12
1:15pm ET
William Blair Reaffirms Their Buy Rating on Enfusion (ENFN)
Mar 12
7:41am ET
Enfusion sees FY24 revenue $200M-$210M, consensus $202.3M
Mar 12
7:40am ET
Enfusion reports Q4 adjusted EPS 4c, consensus 5c
Mar 01
2:01pm ET
Buy/Sell: Wall Street’s top 10 stock calls this week
Mar 01
2:01pm ET
Buy/Sell: Wall Street’s top 10 stock calls this week
Feb 28
9:57am ET
Apollo Global upgraded, Dell initiated: Wall Street’s top analyst calls
Feb 28
4:24am ET
Enfusion downgraded to Sell from Neutral at Goldman Sachs
Feb 27
10:55pm ET
Enfusion Stock Sell Rating: Conservative Revenue Growth and Market Challenges Ahead
Jan 30
6:50am ET
SS&C price target raised to $76 from $71 at JPMorgan
Jan 30
6:13am ET
Enfusion downgraded to Underweight on client risks at JPMorgan
Jan 30
5:14am ET
Enfusion downgraded to Underweight from Neutral at JPMorgan
Jan 18
8:22am ET
Enfusion promotes Valeria Gutowski to chief accounting officer
Dec 22
5:15pm ET
Enfusion (ENFN) Receives a Buy from William Blair
Apr 14
11:17am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
Apr 06
1:18pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
Mar 29
11:14am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
Mar 21
1:21pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
ENFN Financials
Key terms
Ad Feedback
ENFN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ENFN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
